Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...

Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...

IQOS's success in Egypt signals a promising opportunity for the introduction of additional smoke-free products to the market, ...

Stefano Volpetti, President of Smoke-Free Inhalable Products and Consumer Officer at Philip Morris International (PMI), ...

PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...

Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...

The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.

Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...

Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10.Stay Ahead of the ...

Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...

Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...